Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Dr. Jacque Sokolov Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors
PAVmed Inc.April 29, 2021 GMT
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that its major subsidiary Lucid Diagnostics Inc. (“Lucid” or the “Company”) has appointed nationally recognized healthcare executive Jacque J. Sokolov to its Board of Directors (the “Board”). Dr. Sokolov will help establish and serve as the inaugural Chair of the Board’s new Compliance & Quality Committee. He will also serve on Lucid’s Audit and Compensation Committees.
Global Industry Executive Debbie White Joins PAVmed Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, March 10, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today announced that Lishan Aklog, M.D., PAVmed’s Chairman and Chief Executive Officer will present a corporate update at the
Inaugural Emerging Growth Virtual Conference, held by M Vest LLC and Maxim Group LLC. The conference will take place on March 17th - 19th from 9:00 AM to 5:00 PM EDT.
During this virtual conference, the Company will present along with other important voices in the healthcare sector. The conference will feature roundtable discussions, issuer presentations, fireside chats, and live Q&A with company CEOs moderated by Maxim research analysts. To attend and access conference content, sign up to become an M-Vest member for more updates HERE.
PAVmed Announces Closing of its Public Offering of Common Stock
02/25/2021 | 01:38pm EDT
Send by mail :
Message :
NEW YORK, Feb. 25, 2021 (GLOBE NEWSWIRE)
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today announced the closing of its previously announced underwritten public offering (the “Offering”) of approximately 9.8 million shares of its common stock for gross proceeds of approximately $45 million, before deducting underwriting discounts and commissions and other offering expenses payable by PAVmed.
Cantor Fitzgerald & Co. acted as sole bookrunner for the Offering. Lake Street Capital Markets LLC and Maxim Group LLC acted as financial advisors to the Company.
PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.